Cargando…
Thromboprophylaxis in Hospitalized Non-Critically Ill Patients With Mild-to-Moderate COVID-19 Infection: A Systematic Review and Meta-Analysis
The prevalence of venous thromboembolism is high in patients with COVID-19, despite prophylactic anticoagulation. The evidence that supports the preferred thromboprophylaxis regimen in non-critically ill patients with mild to moderate COVID-19 is still limited. Therefore, this systematic review and...
Autores principales: | Hafiz, Awatif, Alkofide, Hadeel, Al Sulaiman, Khalid, Joharji, Hala, Aljohani, Sarah, Sarkhi, Khadijah A., Alharbi, Reem, Korayem, Ghazwa B., AlFaifi, Mashael, Alsohimi, Samiah, Aljuhani, Ohoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408323/ https://www.ncbi.nlm.nih.gov/pubmed/37547931 http://dx.doi.org/10.1177/10760296231191123 |
Ejemplares similares
-
Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in
Critically lll Patients with COVID-19: A Multicenter Cohort Study – New-Onset
Atrial Fibrillation and COVID-19
por: Kensara, Raed, et al.
Publicado: (2023) -
Comparison between standard Vs. Escalated dose venous thromboembolism (VTE) prophylaxis in critically ill patients with COVID-19: A two centers, observational study
por: Aljuhani, Ohoud, et al.
Publicado: (2022) -
A case report on the association between QTc prolongation and remdesivir therapy in a critically ill patient
por: Harbi, Shmeylan Al, et al.
Publicado: (2022) -
Doxycycline’s Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study
por: Al Sulaiman, Khalid, et al.
Publicado: (2023) -
Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study
por: Al Sulaiman, Khalid, et al.
Publicado: (2022)